Washington Post reporter Dan Eggen scored a front page hit on...wait for it...conservative advocacy groups that oppose Obamacare. (See Funding for Health-Care Interest Groups Often Fuzzy.) Eggen is scandalized that (big) business interests want to fund groups that oppose President Obama's plans to socialize insurance in the U.S. Eggen singles out a handful of non-leftists groups and complains about "opaque financing" and "hidden support from insurers, drugmakers [and] unions."

The second part of Eggen's report similarly blasts left-of-center groups that take corporate money to support Obamacare. Yeah, right. Actually, Eggen expends just one paragraph mentioning that liberal groups might be "beholden to labor unions and liberal foundations with deep pockets." No serious discussion of the fact that industry lobbyists have been a huge backer of Obamacare - or, specific provisions thereof. (See, for example, DC Examiner author and columnist Timothy P. Carney's article this week on PhRMA's influence within the Obama administration and, last week, on another major trade association, America's Health Insurance Plans.)

Isn't it curious that Eggen omits entirely any examination of what corporate interests fund left-wing groups?

Author and political reporter Timothy Carney has an interesting item this morning in the Washington Examiner about how Sen. Hillary Clinton (D-N.Y.) practically gets campaign contribution kickbacks from her support for subsidies to the drug industry for the so-called emergency contraceptive pill Plan B. Emphasis mine. (h/t James Joyner):

Sen. Hillary Clinton, D-N.Y., portrays herself as a scourge of the pharmaceutical industry, but she has shown that she’s willing to help a drugmaker if that’s what it takes to profit Planned Parenthood, her indispensable political ally.

Clinton’s campaign Web site touts that she has “battled the big drug companies.” Yet she has sponsored many bills that would directly subsidize Barr Laboratories, maker of the emergency contraceptive pill Plan B, which also functions as an abortifacient. Thanks to a deal cut between Barr and Planned Parenthood, those taxpayer subsidies will yield generous profits for the pro-choice group that every four years spends millions trying to elect a Democrat to the White House.